Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139841
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2005-08-18
Brief Title:
Safety and Efficacy of Treanda Bendamustine HCl in Patients With Indolent Non-Hodgkins Lymphoma NHL Who Are Refractory to Rituximab
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-18
First Submit QC Date:
August 29 2005
Study First Post Date:
2005-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-08
Last Update Post Date:
2014-05-09
Last Update Post Date Type:
ESTIMATED